Over 5400 Hoosiers are diagnosed with Breast Cancer every year. Over 900 of us die.* Hoosier Breast Cancer Advocates are on a mission
to change this statistic and save lives by supporting bi-partisan legislation that positively impacts the Breast Cancer Community in Indiana.
* Indiana Cancer Consortium 2021 Data
HOUSE BILL No. 1058
UNANIMOUSLY PASSES!!
sponsored by State Representative Sharon Negele (Republican, House District 13)
UPDATE: HB 1058 unanimously passed out of the House of Representatives and is scheduled to be heard by the Senate's Health and Provider Services Committee on Wednesday, February 14th.
Synopsis: Breast tissue density. Requires a facility performing a mammography examination to provide: (1) an assessment of the patient's breast tissue density in a specified classifications;(2)written notice to the patient and the referring provider; and (3) concerning the notice to the patient, specified notification language depending on whether the facility determined the patient to have dense breast tissue or not dense breast tissue. Requires the medical licensing board of Indiana to amend an administrative code rule to remove references to
"high breast density" and to align with the breast tissue density classifications in this act.
HB1058 also adds "aesthetic flat closure/chest wall" to the definition of Breast Reconstruction.
Effective: July 1, 2024.
HOUSE BILL No. 1114
UPDATE: Unfortunately, HB 1114 was not assigned to be heard by the House Insurance Committee chaired by Representative Martin Carbaugh (District 81). Therefore, we did not have the opportunity to discuss how this bill will save Hoosier lives. We are hopeful that we will have the opportunity to be heard next legislative session in 2025.
Synopsis: Coverage for cancer screening and prescriptions. Requires a state employee health plan to cover supplemental breast examinations. Requires a policy of accident and sickness insurance and a health maintenance organization to cover diagnostic breast examinations and supplemental breast examinations. Provides that the coverage of diagnostic breast examinations and supplemental breast examinations may not be subject to any cost sharing requirements. Prohibits a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization that provides coverage for advanced, metastatic cancer and associated conditions from requiring that, before providing coverage of a prescription drug, the insured fail to successfully respond to a different prescription drug or prove a history of failure of a different prescription drug. Effective: July 1, 2024.
sponsored by State Representative Cherrish Pryor (Democrat, House District 94)
.png)
